Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3096

1.

Efficacy of Memantine as Adjunct Therapy for Autism Spectrum Disorder in Children Aged <14 Years.

Karahmadi M, Tarrahi MJ, Vatankhah Ardestani SS, Omranifard V, Farzaneh B.

Adv Biomed Res. 2018 Oct 1;7:131. doi: 10.4103/abr.abr_100_18. eCollection 2018.

PMID:
30320040
2.

Compliance and persistence with Alzheimer's disease treatment: a retrospective analysis of multiregional hospital databases in Thailand.

Kongpakwattana K, Dilokthornsakul P, Dejthevaporn C, Pattanaprateep O, Chaiyakunapruk N.

J Med Econ. 2018 Oct 10:1-23. doi: 10.1080/13696998.2018.1534739. [Epub ahead of print]

PMID:
30303420
3.

Available and future treatments for atypical parkinsonism. A systematic review.

Moretti DV.

CNS Neurosci Ther. 2018 Oct 7. doi: 10.1111/cns.13068. [Epub ahead of print] Review.

PMID:
30294976
4.

N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.

Kodis EJ, Choi S, Swanson E, Ferreira G, Bloom GS.

Alzheimers Dement. 2018 Oct;14(10):1302-1312. doi: 10.1016/j.jalz.2018.05.017. Epub 2018 Jul 4.

PMID:
30293574
5.

Preventive effect of oral magnesium in postmastectomy pain: protocol for a randomised, double-blind, controlled clinical trial.

Morel V, Joly D, Villatte C, Pereira B, Pickering G.

BMJ Open. 2018 Oct 4;8(9):e017986. doi: 10.1136/bmjopen-2017-017986.

6.

Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.

Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW.

JAMA Neurol. 2018 Oct 1. doi: 10.1001/jamaneurol.2018.2820. [Epub ahead of print]

PMID:
30285047
7.

France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer's Disease.

Krolak-Salmon P, Dubois B, Sellal F, Delabrousse-Mayoux JP, Vandel P, Amieva H, Jeandel C, Andrieu S, Perret-Liaudet A.

J Alzheimers Dis. 2018 Sep 28. doi: 10.3233/JAD-180843. [Epub ahead of print]

PMID:
30282371
8.

Stroke as a cause of death in death certificates of patients with dementia: a cohort study from the Swedish Dementia Registry.

Subic A, Zupanic E, von Euler M, Norrving B, Cermakova P, Religa D, Winblad B, Kramberger MG, Eriksdotter M, Garcia-Ptacek S.

Curr Alzheimer Res. 2018 Oct 2. doi: 10.2174/1567205015666181002134155. [Epub ahead of print]

PMID:
30280666
9.

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice.

García-Pardo MP, Miñarro J, Llansola M, Felipo V, Aguilar MA.

Eur J Neurosci. 2018 Oct 1. doi: 10.1111/ejn.14190. [Epub ahead of print]

PMID:
30276890
10.

The Future Is Now-Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!

Roberge D, Brown PD, Whitton A, O'Callaghan C, Leis A, Greenspoon J, Smith GL, Hu JJ, Nichol A, Winch C, Chan MD.

Front Oncol. 2018 Sep 13;8:380. doi: 10.3389/fonc.2018.00380. eCollection 2018.

11.

Connectomic imaging reveals Huntington-related pathological and pharmaceutical effects in a mouse model.

Chang WT, Puspitasari F, Garcia-Miralles M, Yeow LY, Tay HC, Koh KB, Tan LJ, Pouladi MA, Chuang KH.

NMR Biomed. 2018 Sep 27:e4007. doi: 10.1002/nbm.4007. [Epub ahead of print]

PMID:
30260561
12.

Pharmacotherapy of Down syndrome.

Palumbo ML, McDougle CJ.

Expert Opin Pharmacother. 2018 Sep 26:1-15. doi: 10.1080/14656566.2018.1529167. [Epub ahead of print]

PMID:
30257591
13.

Dementia-specific drug treatment in home care settings: A German multicentre study.

Schütz LH, Boronat-Garrido X, Moser FA, Suhr R, Lahmann N.

J Clin Nurs. 2018 Sep 26. doi: 10.1111/jocn.14682. [Epub ahead of print]

PMID:
30256473
14.

Acetate Mediates Alcohol Excitotoxicity in Dopaminergic-Like PC12 Cells.

Chapp AD, Behnke JE, Driscoll KM, Fan Y, Hoban E, Shan Z, Zhang L, Chen QH.

ACS Chem Neurosci. 2018 Sep 24. doi: 10.1021/acschemneuro.8b00189. [Epub ahead of print]

PMID:
30247872
15.

An evaluation of memantine ER + donepezil for the treatment of Alzheimer's disease.

Calhoun A, King C, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2018 Sep 23:1-7. doi: 10.1080/14656566.2018.1519022. [Epub ahead of print]

PMID:
30244611
16.

Current approaches to the pharmacological treatment of Alzheimer's disease.

Tan EC, Hilmer SN, Garcia-Ptacek S, Bell JS.

Aust J Gen Pract. 2018 Sep;47(9):586-592.

PMID:
30244564
17.

Prenatal Deltamethrin Exposure-Induced Cognitive Impairment in Offspring Is Ameliorated by Memantine Through NMDAR/BDNF Signaling in Hippocampus.

Zhang C, Xu Q, Xiao X, Li W, Kang Q, Zhang X, Wang T, Li Y.

Front Neurosci. 2018 Sep 4;12:615. doi: 10.3389/fnins.2018.00615. eCollection 2018.

18.

The efficacy and safety of memantine for the treatment of Alzheimer's disease.

Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N.

Expert Opin Drug Saf. 2018 Oct;17(10):1053-1061. doi: 10.1080/14740338.2018.1524870. Epub 2018 Sep 26.

PMID:
30222469
19.

Adenosine A2A Receptors Facilitate Synaptic NMDA Currents in CA1 Pyramidal Neurons.

Mouro F, Rombo DM, Dias RB, Ribeiro JA, Sebastião AM.

Br J Pharmacol. 2018 Sep 16. doi: 10.1111/bph.14497. [Epub ahead of print]

PMID:
30220081
20.

Memantine attenuated alcohol withdrawal-induced anxiety-like behaviors through down-regulating NR1-CaMKII-ERK signaling pathway.

Yuanyuan J, Junyan Z, Cuola D, Jingjing C, Yuhui S, Dan X, Wei D, Yongsheng Z.

Neurosci Lett. 2018 Sep 10;686:133-139. doi: 10.1016/j.neulet.2018.09.006. [Epub ahead of print]

PMID:
30213620

Supplemental Content

Loading ...
Support Center